Negative overtures persuade Sanofi to withdraw drug filing

Sanofi has withdrawn its marketing applications worldwide for its drug Mulsevo. Designed to stop blood clots in cancer patients receiving chemotherapy for locally-advanced or metastatic solid tumours,…
Read the full story: InPharm